MentionFox
Home › Executive changes › LeonaBio, Inc.
Leadership changes · LONA · SEC Form 8-K, Item 5.02

Leadership changes at LeonaBio, Inc. (2026)

Before you join, sell to or invest in LeonaBio, Inc.

MentionFox check on LeonaBio, Inc.: only 2 sources on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/leonabio

  • Note: Layoff plan disclosed Sep 2024 (about 49 employees) (filing)

New since last check: Layoff plan disclosed Sep 2024 (about 49 employees) (filing, first seen 14 November 2026).

Check LeonaBio, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about LeonaBio, Inc.?

Who joined and who left LeonaBio, Inc. (LONA)? 1 filing reported on 2026-03-19, each cited to the company's own filing.

As of November 14, 2026, LeonaBio, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 19, 2026 (Form 8-K, March 19, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Oliveira Steven Michael also filed stake reports on 1 other company ↓

Sell to companies like LeonaBio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-03-19

LeonaBio, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-19. Every row below is cited to the filing it comes from, and this page adds each new change as LeonaBio, Inc. files it.

Layoffs on record: about 49 jobs, latest 2024-09-17 (layoff filings and notices).

Also on the record for LeonaBio, Inc.

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G, by Spruce Street Capital LP4.2% of the class5%+ stakesSource
November 4, 2026Stake report, Schedule 13G, by Great Point Partners, LLC5.03% of the class5%+ stakesSource
October 28, 2026Stake report, Schedule 13D/A, by Sermonix Pharmaceuticals, Inc.25.1% of the class5%+ stakesSource
October 26, 2026Stake report, Schedule 13D/A, by Perceptive Advisors LLC19.99% of the class5%+ stakesSource
August 31, 2026Stake report, Schedule 13D, by Sermonix Pharmaceuticals, Inc.36.9% of the class5%+ stakesSource
August 25, 2026Stake report, Schedule 13D/A, by Perceptive Advisors LLC19.99% of the class5%+ stakesSource
August 20, 2026Stake report, Schedule 13G/A, by Anders Hove12.1% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G, by ADAR1 Capital Management, LLC7.7% of the class5%+ stakesSource
May 7, 2026Stake report, Schedule 13D/A, by Perceptive Advisors LLC19.99% of the class5%+ stakesSource
February 6, 2026Stake report, Schedule 13G/A, by Baselake Partners, LP1.9% of the class5%+ stakesSource
January 16, 2026Stake report, Schedule 13D/A, by Perceptive Advisors LLC19.99% of the class5%+ stakesSource
January 8, 2026Stake report, Schedule 13G/A, by Anders Hove6.2% of the class5%+ stakesSource

Selling to them or working with them? See who runs LeonaBio, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on LeonaBio, Inc. and the records around it.

LeonaBio, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on LeonaBio, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on LeonaBio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on LeonaBio, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    14 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 18 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-03-19Reportednot named in the filing8-K, 2026-03-19
Selling to LeonaBio, Inc.?

New leaders reset buying decisions — get the Full Report on LeonaBio, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch LeonaBio, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at LeonaBio, Inc., with the record behind each one.

Find candidates like senior executive at LeonaBio, Inc.

Every change, in the filing's words

Filed 2026-03-19 · 8-K

Reported

There will be no further grants under the Company's prior company-wide equity plan, the 2020 Equity Incentive Plan (the "2020 Plan"), which terminated for future use upon stockholder approval of the 2026 Plan.

Also stated in this filing

  • The Company's board of directors (the "Board") previously approved, subject to stockholder approval, the Company's 2026 Equity Incentive Plan (the "2026 Plan").
  • At the Special Meeting, the Company's stockholders approved the 2026 Plan.
  • Termination of the 2020 Plan will not affect outstanding awards previously issued pursuant to the 2020 Plan.
  • The purposes of the 2026 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to employees, directors, and consultants, and to promote the success of the Company's business.
  • These incentives are provided through the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, and performance awards as the administrator of the 2026 Plan may determine.
  • Subject to adjustment upon changes in capitalization of the Company as provided in the 2026 Plan, up to 5,700,000 shares may be issued under the 2026 Plan.
  • For additional information regarding the 2026 Plan, please refer to Proposal 4 of the Company's definitive proxy statement filed with the United States Securities and Exchange Commission on February 23, 2026, as amended on March 10, 2026 (together, the "Proxy Statement").

Tools for this story

Each opens in a new tab, filled in for LeonaBio, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/leonabio
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of LeonaBio, Inc.? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/leonabio